Marco High-Cost Drugs enables oncologists to access updated information on high-cost drugs and rare diseases in seconds: indications, eligibility criteria, available evidence, and access pathways. Directly from WhatsApp or the web.
Some answers to questions we often receive
Yes. Marco High-Cost Drugs includes information on drugs approved in other jurisdictions and access options through off-label use or expanded and compassionate access programs.
Marco High-Cost Drugs includes information on regional availability and, where available, references to patient access programs offered by manufacturers.
Marco High-Cost Drugs is initially focused on oncology and rare diseases with high therapeutic burden. The database is progressively expanding to other specialties with high-cost drugs and unmet medical needs.
Yes. Each drug profile includes required and recommended predictive biomarkers according to available clinical evidence, facilitating the selection of candidate patients.
Yes. Marco High-Cost Drugs includes updated information on active clinical trials with inclusion and exclusion criteria, participating centers, and contact details, facilitating the referral of patients to clinical research options.
Yes. Marco High-Cost Drugs generates a structured summary of the available clinical evidence for the specific drug and indication, which the physician can use as supporting documentation in coverage requests to insurers or public health systems.
Oncologists treating patients with rare tumors or evaluating innovative therapies need specialized information not readily available in standard clinical guidelines.
